Isabelle Dubuc

2.0k total citations
52 papers, 1.5k citations indexed

About

Isabelle Dubuc is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Isabelle Dubuc has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 24 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in Isabelle Dubuc's work include Neuropeptides and Animal Physiology (23 papers), Receptor Mechanisms and Signaling (17 papers) and COVID-19 Clinical Research Studies (10 papers). Isabelle Dubuc is often cited by papers focused on Neuropeptides and Animal Physiology (23 papers), Receptor Mechanisms and Signaling (17 papers) and COVID-19 Clinical Research Studies (10 papers). Isabelle Dubuc collaborates with scholars based in France, Canada and United States. Isabelle Dubuc's co-authors include Jean Costentin, Louis Flamand, Patrick Kitabgi, Philippe Protais, Éric Boilard, Jean Martínez, Antoine Coquerel, Annie Gravel, William Rostène and Matthieu Rousseau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Neuroscience.

In The Last Decade

Isabelle Dubuc

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabelle Dubuc France	24	701	686	232	220	212	52	1.5k
Takashi Toya Japan	20	658 0.9×	925 1.3×	227 1.0×	127 0.6×	196 0.9×	83	1.7k
Jerzy Trojnar Sweden	16	243 0.3×	464 0.7×	113 0.5×	146 0.7×	163 0.8×	36	1.3k
J. Verhoef Netherlands	24	584 0.8×	568 0.8×	82 0.4×	142 0.6×	263 1.2×	42	1.6k
P. Donatsch Switzerland	19	575 0.8×	927 1.4×	88 0.4×	111 0.5×	258 1.2×	45	2.2k
R. William Hipkin United States	29	725 1.0×	1.1k 1.7×	125 0.5×	368 1.7×	648 3.1×	47	3.0k
Jonathan W. Nyce United States	22	178 0.3×	751 1.1×	68 0.3×	63 0.3×	110 0.5×	49	1.4k
Sandra E. Reznik United States	21	143 0.2×	400 0.6×	72 0.3×	239 1.1×	228 1.1×	76	1.2k
Anja Meißner Germany	23	139 0.2×	475 0.7×	39 0.2×	130 0.6×	128 0.6×	50	1.5k
Stephen G. Farmer United States	30	657 0.9×	766 1.1×	54 0.2×	144 0.7×	177 0.8×	51	2.4k
Roman L. Zastawny Canada	11	331 0.5×	671 1.0×	82 0.4×	54 0.2×	528 2.5×	11	1.2k

Countries citing papers authored by Isabelle Dubuc

Since Specialization

Citations

This map shows the geographic impact of Isabelle Dubuc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Dubuc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Dubuc more than expected).

Fields of papers citing papers by Isabelle Dubuc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Dubuc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Dubuc. The network helps show where Isabelle Dubuc may publish in the future.

Co-authorship network of co-authors of Isabelle Dubuc

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Dubuc. A scholar is included among the top collaborators of Isabelle Dubuc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Dubuc. Isabelle Dubuc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bayega, Anthony, Sarah J. Reiling, Jun‐Li Liu, et al.. (2025). A Benchmark of methods for SARS-CoV-2 whole genome sequencing and development of a more sensitive method. Frontiers in Genetics. 16. 1516791–1516791.

Allaeys, Isabelle, Guillaume Lemaire, Mickaël Leclercq, et al.. (2024). SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrow. Blood Advances. 8(11). 2777–2789. 3 indexed citations

Willett, Julian, Annie Gravel, Isabelle Dubuc, et al.. (2024). SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice. Communications Biology. 7(1). 191–191. 7 indexed citations

Dubuc, Isabelle, Nicolas Flamand, Louis Flamand, et al.. (2024). Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator. Frontiers in Pharmacology. 15. 1303342–1303342. 2 indexed citations

Puhm, Florian, Isabelle Allaeys, Isabelle Dubuc, et al.. (2022). Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells. Blood Advances. 6(12). 3593–3605. 40 indexed citations

Bolduc, Marilène, Pierre Savard, Isabelle Dubuc, et al.. (2022). A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection. Nanomedicine Nanotechnology Biology and Medicine. 44. 102584–102584. 8 indexed citations

Zaid, Younes, Étienne Doré, Isabelle Dubuc, et al.. (2021). Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. Journal of Allergy and Clinical Immunology. 148(2). 368–380.e3. 55 indexed citations

Peddu, Vikas, Isabelle Dubuc, Annie Gravel, et al.. (2019). Inherited Chromosomally Integrated Human Herpesvirus 6 Demonstrates Tissue-Specific RNA Expression In Vivo That Correlates with an Increased Antibody Immune Response. Journal of Virology. 94(1). 20 indexed citations

Gravel, Annie, Isabelle Dubuc, Guillaume Morissette, et al.. (2015). Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris. Proceedings of the National Academy of Sciences. 112(26). 8058–8063. 71 indexed citations

10.

Galusca, Bogdan, Gaëtan Prévost, Natacha Germain, et al.. (2015). Neuropeptide Y and α-MSH Circadian Levels in Two Populations with Low Body Weight: Anorexia Nervosa and Constitutional Thinness. PLoS ONE. 10(3). e0122040–e0122040. 41 indexed citations

11.

Gravel, Annie, Isabelle Dubuc, Nina Wallaschek, et al.. (2015). Characterization of human herpesvirus 6A/B U94 as ATPase, helicase, exonuclease and DNA-binding proteins. Nucleic Acids Research. 43(12). 6084–6098. 28 indexed citations

12.

Dong, Congcong, et al.. (2001). Developmental changes of 3H-labelled μ-opioid receptors in brainstems of intra-uterine growth-restricted rats. Developmental Brain Research. 126(2). 211–215. 3 indexed citations

13.

Dubuc, Isabelle, et al.. (1999). The partial agonist properties of levocabastine in neurotensin-induced analgesia. European Journal of Pharmacology. 381(1). 9–12. 37 indexed citations

14.

Dubuc, Isabelle, et al.. (1996). A C-terminal cyclic 8–13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice. Neuroscience Letters. 217(1). 58–60. 10 indexed citations

15.

Dubuc, Isabelle, Jean Costentin, Jean-Paul Terranova, et al.. (1994). The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. British Journal of Pharmacology. 112(2). 352–354. 106 indexed citations

16.

Kitabgi, Patrick, Catherine Labbé‐Jullié, Isabelle Dubuc, et al.. (1992). FUNCTIONAL AND PHARMACOLOGICAL ASPECTS OF CENTRAL NEUROPEPTIDERGIC TRANSMISSION MEDIATED BY NEUROTENSIN AND NEUROMEDIN N. Clinical Neuropharmacology. 15. 313A–314A. 15 indexed citations

17.

Dubuc, Isabelle, et al.. (1992). JMV 449: A pseudopeptide analogue of neurotensin-(8–13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse. European Journal of Pharmacology. 219(2). 327–329. 32 indexed citations

18.

Kitabgi, Patrick, Isabelle Dubuc, Dominique Nouel, et al.. (1992). Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus. Neuroscience Letters. 142(2). 200–204. 19 indexed citations

19.

Coquerel, Antoine, et al.. (1988). Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin n. Neurochemistry International. 12(3). 361–366. 49 indexed citations

20.

Dubuc, Isabelle, Dominique Nouel, Antoine Coquerel, et al.. (1988). Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors. European Journal of Pharmacology. 151(1). 117–121. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact